Mary Elizabeth Strek to Aged
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Aged.
Connection Strength
0.879
-
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023 03 01; 6(3):e232427.
Score: 0.068
-
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018 06; 51(6).
Score: 0.049
-
CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines. AJR Am J Roentgenol. 2018 May; 210(5):1034-1041.
Score: 0.048
-
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol. 2018 Feb; 210(2):307-313.
Score: 0.047
-
De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy. Chest. 2017 09; 152(3):683-685.
Score: 0.046
-
CT findings associated with survival in chronic hypersensitivity pneumonitis. Eur Radiol. 2017 Dec; 27(12):5127-5135.
Score: 0.046
-
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016 12; 121:117-122.
Score: 0.044
-
Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016 06; 47(6):1767-75.
Score: 0.042
-
Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
Score: 0.042
-
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther. 2016 Feb; 36:46-52.
Score: 0.041
-
Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture. Chest. 2012 Jul; 142(1):159-167.
Score: 0.032
-
Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011 Nov; 140(5):1292-1299.
Score: 0.030
-
High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2021 11 24; 11(1):22821.
Score: 0.016
-
Hospitalizations in patients with idiopathic pulmonary fibrosis. Respir Res. 2021 Sep 30; 22(1):257.
Score: 0.015
-
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. Am J Respir Crit Care Med. 2021 07 15; 204(2):197-208.
Score: 0.015
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.015
-
CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest. 2020 10; 158(4):1701-1712.
Score: 0.014
-
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020 10; 158(4):1526-1534.
Score: 0.014
-
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 03 01; 201(5):564-574.
Score: 0.014
-
Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease. Am J Respir Crit Care Med. 2020 01 15; 201(2):250-253.
Score: 0.014
-
Diagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019 Nov 12; 20(1):253.
Score: 0.013
-
Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019 10; 156(4):715-723.
Score: 0.013
-
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.
Score: 0.013
-
Telomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J. 2019 04; 53(4).
Score: 0.013
-
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation. Am J Respir Crit Care Med. 2019 03 15; 199(6):747-759.
Score: 0.013
-
Anti-RNA binding protein positivity in idiopathic interstitial pneumonia. Respir Med. 2019 01; 146:23-27.
Score: 0.013
-
Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018 06; 15(6):764-766.
Score: 0.012
-
N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia. BMC Pulm Med. 2018 Feb 08; 18(1):30.
Score: 0.012
-
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.
Score: 0.012
-
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
Score: 0.011
-
Interstitial Pneumonia With Autoimmune Features: Value of Histopathology. Arch Pathol Lab Med. 2017 Jul; 141(7):960-969.
Score: 0.011
-
Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med. 2017 02; 123:56-62.
Score: 0.011
-
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015 Dec 15; 192(12):1475-82.
Score: 0.010
-
A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med. 2015 Nov 21; 15:147.
Score: 0.010
-
Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2015 Sep; 148(3):692-700.
Score: 0.010
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2083-92.
Score: 0.009
-
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.
Score: 0.009
-
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013 May 07; 158(9):641-9.
Score: 0.009
-
Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2012 Feb; 39(2):344-51.
Score: 0.008
-
Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol. 2009 Aug; 15(5):254-5.
Score: 0.007
-
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest. 2006 Jan; 129(1):56-66.
Score: 0.005
-
Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respir Med. 2001 Jan; 95(1):1-4.
Score: 0.004